Two UK institutions have stepped up their support for gene therapy with a £3.1 million award to a consortium that is investigating an experimental treatment for cystic fibrosis. The therapy is poised to enter Phase 2 development. ---Subscribe to MedNous to access this article--- Regenerative Medicine
